Publications by authors named "Yuko Kaneko"

Claim this Profile
S
Serum interleukin-1 receptor antagonist levels are a useful marker of disease activity and risk of relapse in large vessel vasculitis.
Koji Suzuki, Sho Ishigaki, Mitsuhiro Akiyama, Keiko Yoshimoto, Waleed Alshehri, Yuko Kaneko

Cytokine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct predictors of peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitis: KEIO-vasculitis cohort.
Yuki Imai, Sho Ishigaki, Mitsuhiro Akiyama, Yuko Kaneko

Semin Arthritis Rheum· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-survival of motor neuron antibodies in rheumatic and musculoskeletal diseases: prevalence, clinical associations, and biomarker potential, with novel insights into disease activity in SLE.
Yuki Imai, Masaru Takeshita, Koji Suzuki, Hiroyuki Fukui, Kazunori Furuhashi, Yuko Kaneko

Inflamm Regen· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study.
Ami Inokuchi, Haryoon Kim, Masatoshi Sakurai, Kyoko Masuda, Kota Mizuno, Yuko Kaneko

Blood Cancer J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of BHLHE40-expressing T cells in giant cell arteritis amplified by interleukin-1.
Sho Ishigaki, Katsuya Suzuki, Kazuhiro Yamanoi, Takashi Nishina, Yoichiro Iwakura, Yuko Kaneko

Immunol Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment.
Nancy Agmon-Levin, Stanislav Ignatenko, Alexander Gordienko, Josefina Cortés-Hernández, Pongthorn Narongroeknawin, Yuko Kaneko, Hiroshi Kaneko

Ann Rheum Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of nintedanib continuation in systemic autoimmune rheumatic disease-related progressive pulmonary fibrosis: KEIO-SARD-ILD-cohort.
Koji Suzuki, Mitsuhiro Akiyama, Kanako Shimanuki, Hiroyuki Fukui, Yuko Kaneko

Semin Arthritis Rheum· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptability and Barriers to Implementation of the EULAR Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis: A Mixed-Methods Study With Nurses and Rheumatologists in Japan.
Mie Fusama, Hideko Nakahara, Yuko Kaneko, Sarah E Bennett, Mwidimi Ndosi

Int J Rheum Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to a letter to the editor entitled "CMV Reactivation in RMDs: Are We Capturing the Full Picture?" by You et al.
Yuichiro Ota, Masaru Takeshita, Yasushi Kondo, Shuntaro Saito, Jun Kikuchi, Yuko Kaneko

Clin Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of disseminated and chronic varicella zoster virus infection with persistent ulcer formation in a rheumatoid vasculitis patient treated with immunosuppressants.
Risa Kakuta, Yoshio Nakamura, Kenta Kobayashi, Kaede Sawada, Risa Uchikawa, Yuko Kaneko

JAAD Case Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicentre, Prospective Registry of Patients with Systemic Sclerosis in Japan: Baseline Patient Characteristics.
Masataka Kuwana, Shinji Watanabe, Tohru Takeuchi, Yuko Kaneko, Yasushi Kawaguchi

Mod Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study.
Rangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, Vera Golder, Yi-Hsing Chen, Yuko Kaneko

Lupus Sci Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retention of baricitinib-treated patients with rheumatoid arthritis in Japan: Interim results from a prospective observational cohort study.
Yuko Kaneko, Chaochen Wang, Naoto Tsujimoto, Masaru Tanaka, Kei Ikeda

Mod Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study.
Satoshi Takanashi, Masatoshi Kawai, Mitsuhiro Akiyama, Yasushi Kondo, Shuntaro Saito, Yuko Kaneko

Immunol Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Urinary Fractional Excretion of Potassium and Proteinuria Remission in Adult Nephrotic Syndrome.
Ryuto Yoshida, Takashin Nakayama, Ryunosuke Mitsuno, Motoaki Komatsu, Yoichi Oshima, Yuko Kaneko

Kidney360· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of the treatment of rheumatoid arthritis patients of reproductive age: Informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis - secondary publication.
Mikako Goto, Chie Kohno, Chinatsu Takai, Eiko Miyagawa, Ryo Yanai, Yuko Kaneko, Kayoko Kaneko

Mod Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-occurrence of IgG4-related disease and mucous membrane pemphigoid: implication of shared IgG4-driven pathogenesis.
Koji Suzuki, Mitsuhiro Akiyama, Kanako Shimanuki, Koichi Saito, Yuko Kaneko

Rheumatology (Oxford)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates on the pathogenesis and molecular-targeted therapies of Still's disease.
Koji Suzuki, Yuko Kaneko

Immunol Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong inhibition of IL-6 signal is clinically and serologically effective in refractory adult-onset Still's disease.
Koji Suzuki, Hideto Kameda, Kei Ikeda, Tomonori Ishii, Kosaku Murakami, Yuko Kaneko

Rheumatology (Oxford)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-RuvBL1/2 Antibodies in Scleromyositis: A Clinicopathological Report of Two Cases.
Yuki Imai, Masaru Takeshita, Yasushi Kondo, Jun Kikuchi, Junko Kuramoto, Yuko Kaneko

ACR Open Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative single-cell and spatial profiling of anti-SSA-positive and anti-centromere-positive Sjögren's disease reveals common and distinct immune activation and fibroblast-mediated inflammation.
Jun Inamo, Masaru Takeshita, Katsuya Suzuki, Kazuyuki Tsunoda, Satoshi Usuda, Yuko Kaneko

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urine-to-blood urea nitrogen ratio predicts proteinuria remission in nephrotic syndrome.
Ryunosuke Mitsuno, Takashin Nakayama, Ryuto Yoshida, Motoaki Komatsu, Yoichi Oshima, Yuko Kaneko

Clin Exp Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs associated with tumour necrosis factor or fibloblast-like synoviocyte predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab: a subanalysis of the MIRACLE study.
Yohei Hosokawa, Yusuke Yoshida, Hiroya Tamai, Shintaro Hirata, Kei Ikeda, Yuko Kaneko

Clin Exp Rheumatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated IgG4-related prostatitis masquerading as prostate cancer: a diagnostic pitfall in patients with elevated prostate-specific antigen and prostatic mass.
Koji Suzuki, Mitsuhiro Akiyama, Koichi Saito, Kanako Shimanuki, Yuko Kaneko

Rheumatol Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of tocilizumab in the management of polymyalgia rheumatica: a retrospective study from the KEIO-PMR cohort.
Yuki Imai, Satoshi Takanashi, Yuko Kaneko

Rheumatol Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis